Domov › Steatotična bolezen jeter › Texas › San Antonio
Klinične študije za Steatotična bolezen jeter v San Antonio, TX
17 študij za Steatotična bolezen jeter išče udeležence na lokacijah v San Antonio in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Vključevanje udeležencevFaza 3
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Vključevanje udeležencevFaza 3
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- in še 2
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Vključevanje udeležencevFaza 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Vključevanje udeležencevFaza 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Vključevanje udeležencevFaza 2
- American Research Corporation at The Texas Liver Institute, San Antonio
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Vključevanje udeležencevFaza 2
- American Research Corporation at The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research - San Antonio, San Antonio
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Vključevanje udeležencevFaza 3
- American Research Corporation at Texas Liver Institute, San Antonio
- Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
- IMA Clinical Research San Antonio, San Antonio
- in še 1
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Vključevanje udeležencevFaza 3
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- in še 2
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Vključevanje udeležencevFaza 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Vključevanje udeležencevFaza 2
- Quality Research, Inc., San Antonio
- Pinnacle Clinical Research - South San Antonio, San Antonio
- Pinnacle Clinical Research, San Antonio
Quantifying Hepatic Mitochondrial Fluxes in Humans
Vključevanje udeležencevFaza 4
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Vključevanje udeležencevFaza 2
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Vključevanje udeležencevFaza 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Vključevanje udeležencevFaza 2
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Vključevanje udeležencevFaza 1
- GSK Investigational Site, San Antonio
Evaluating the Pharmacokinetics and Safety of Miricorilant
Vključevanje udeležencevFaza 1
- Site# 433, San Antonio
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Vključevanje udeležencevOpazovalna študija
- Endeavor Clinical Trials, San Antonio
Študije za Steatotična bolezen jeter v drugih mestih
- New York City, NY16 študij
- Miami, FL16 študij
- San Diego, CA14 študij
- Austin, TX13 študij
- Houston, TX13 študij
- Richmond, VA12 študij
- Tucson, AZ10 študij
- Chandler, AZ10 študij
- Hialeah, FL9 študij
- Dallas, TX9 študij
- Orlando, FL9 študij
- St. Louis, MO9 študij
Druge študije v San Antonio
- Nemalicelični pljučni rak59 študij
- Rak dojke47 študij
- Kolorektalni rak46 študij
- Metastatski rak44 študij
- Rak (vse vrste)41 študij
- Debelost40 študij
- Sladkorna bolezen tipa 237 študij
- Prekomerna telesna teža34 študij
- Rak jajčnikov31 študij
- Rak trebušne slinavke31 študij
- Rak prostate28 študij
- Rak endometrija27 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.